{"id":"W2754989230","doi":"10.1136/annrheumdis-2017-eular.2155","title":"SAT0548 Plasma CGRP concentrations were not associated with patient OA symptoms or response to galcanezumab, a monoclonal antibody against CGRP","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Calcitonin gene-related peptide; Celecoxib; Medicine; Osteoarthritis; Placebo; WOMAC; Internal medicine; Gastroenterology; Interim analysis; Randomized controlled trial; Pathology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003600708,0.0003375838,0.0006595857,0.0003402029,0.0002037208,0.000477886,0.0001956379,0.0005120033,0.003290547],"category_scores_gemma":[0.001652707,0.0001184843,0.0005748585,0.0003311239,0.0002612165,0.0003535072,0.0001415214,0.000747962,0.0004799782],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000250466,"about_ca_system_score_gemma":0.0002188837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004812867,"about_ca_topic_score_gemma":0.0009826116,"domain_scores_codex":[0.9995531,0.00006478098,0.00006536562,0.00008667925,0.0001362526,0.00009370813],"domain_scores_gemma":[0.9988911,0.0004737967,0.0003123525,0.0000775528,0.0001099323,0.0001354209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02270333,0.0007410251,0.873938,0.0003723015,0.001562744,0.002489053,0.0002660965,0.0002581973,0.05887714,0.0001660934,0.0008683628,0.03775762],"study_design_scores_gemma":[0.0002055994,0.004039215,0.9860206,0.00002388009,0.0004955443,0.003005171,0.00008127686,0.0007924227,0.003806327,0.00009269291,0.001423176,0.00001416593],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965899,0.0007064228,0.000238141,0.00006606381,0.00003213362,0.00001890781,0.0003111848,0.00002295124,0.002014333],"genre_scores_gemma":[0.9992048,0.000065152,0.00008151693,0.00005082417,0.00001776985,0.000007194499,0.0002277418,0.00000310568,0.0003420059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003290547,"threshold_uncertainty_score":0.01100791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03058403615896824,"score_gpt":0.3188972271753703,"score_spread":0.288313191016402,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}